Live Earnings Conference Call: Novartis will host a live Q3 2026 earnings call on October 27, 2026 at 8:00AM ET. NYSE:NVS Novartis Q3 2026 Earnings Date & Estimates $153.93 +2.81 (+1.86%) Closing price 10/26/2026 03:59 PM EasternExtended Trading$156.28 +2.35 (+1.52%) As of 05:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Novartis is estimated to report Q3 2026 earnings on Tuesday, October 27, 2026, before market opens. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 27, 2026TimeBefore Market OpensConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) Live Call not available Upcoming EventEarnings Conference CallNovartis Q3 202600:00 / 00:00Live Transcript Follow Audio What Analysts Expect from Novartis in Q3 2026Novartis is expected to post earnings of $2.25 per share on revenue of $14.53 billion. In the same quarter a year earlier Novartis reported $2.25 per share on revenue of $14.36 billion. Novartis last reported on July 21, 2026, posting $2.41 per share and beating the $2.17 consensus estimate. Novartis has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS$2.25Expected Revenue$14.53 billionPrior-Year EPS$2.25Prior-Year Revenue$14.36 billionExpected EPS Growth0.0%Expected Revenue Growth+1.2%Recent Track RecordLast ReportedQ2Last Quarter EPS$2.41 (Beat by +$0.24)Last Quarter Revenue$14.41 billionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallSlide DeckPress ReleaseInterim ReportEarnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Q2 Earnings ReportQ2 2026 Earnings ReportQ1 2026 Earnings Report Earnings DocumentsPress ReleaseInterim report Novartis Q3 2026 Earnings FAQ When does Novartis report Q3 2026 earnings? Novartis (NYSE:NVS) is estimated to report Q3 2026 earnings on Tuesday, October 27, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Novartis' Q3 2026 earnings call? Novartis' Q3 2026 earnings conference call is scheduled for Tuesday, October 27, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Novartis? Analysts expect Novartis to post earnings of $2.25 per share for Q3 2026. How much revenue is Novartis expected to report? The consensus revenue estimate for Novartis is $14.53 billion for Q3 2026. Novartis Earnings HeadlinesNovartis Q3 Profit Declines; Lifts FY26 Core Income View, Backs Sales Outlook 2 hours ago | rttnews.comNovartis (NYSE:NVS) Shares Cross Above 200 Day Moving Average - What's Next?2 hours ago | americanbankingnews.comWould Anthropic IPO Burst the Bubble?The biggest IPO in history is likely just weeks away… Anthropic, the company behind Claude AI, is rumoured to be lining up a Nasdaq debut before Thanksgiving… at a valuation of up to $2 trillion. But here’s what nobody’s talking about… A raise of about $100 billion doesn’t just make headlines. It puts an enormous spotlight on the AI industry. And as investors rush to find the next big opportunity in artificial intelligence, some of the most interesting plays may be hiding outside traditional AI stocks. | Crypto 101 Media (Ad)Novartis Raises Guidance Despite Trial Setbacks Hitting Profit2 hours ago | wsj.comNovartis reports lower relapse rates and no Hy’s Law cases in phase 3 Remibrutinib MS trialsOctober 26 at 3:03 PM | msn.comNovartis (NVS) Projected to Announce Earnings on TuesdayOctober 26 at 2:10 AM | americanbankingnews.comSee More Novartis Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Novartis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novartis and other key companies, straight to your email. Email Address About NovartisNovartis (NYSE:NVS) is a Switzerland-based pharmaceutical company focused on the discovery, development and commercialization of innovative medicines. The company’s research and commercial activities span areas including cardiovascular, renal and metabolic diseases, immunology, neuroscience, oncology and hematology. Its portfolio includes prescription medicines such as Entresto, Cosentyx, Kisqali, Kesimpta, Leqvio, Pluvicto and Scemblix. Novartis serves patients and healthcare providers in markets around the world. In addition to traditional pharmaceutical products, the company develops targeted therapies, radioligand treatments and other advanced medicines intended to address diseases with significant unmet medical needs. Novartis was formed in 1996 through the merger of Ciba-Geigy and Sandoz and is headquartered in Basel, Switzerland. The company separated its generic and biosimilar medicines business, Sandoz, as an independent company in 2023, allowing Novartis to concentrate on innovative medicines. Vas Narasimhan serves as chief executive officer.View Novartis ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure GiantsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big CatalystsComfort Systems Earnings: AI Slowdown or More Growth Ahead?MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline Upcoming Earnings T-Mobile US (10/28/2026)Alphabet (10/28/2026)Alphabet (10/28/2026)Carvana (10/28/2026)eBay (10/28/2026)Garmin (10/28/2026)O'Reilly Automotive (10/28/2026)Equinor ASA (10/28/2026)Phillips 66 (10/28/2026)AON (10/28/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
